Doctor D. Schwab Controlling Balm with Tea Tree Oil
Recalled by CA BOTANA International, Inc.
Drug recall
CA BOTANA International, Inc.
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
CA BOTANA International, Inc. has recalled Doctor D. Schwab Controlling Balm with Tea Tree Oil, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on December 3, 2025 and was initiated on October 10, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Doctor D. Schwab Controlling Balm with Tea Tree Oil, with approximately 555 tubes affected. The company behind the recall is CA BOTANA International, Inc., based in San Diego, CA. The FDA describes the product as: “Doctor D. Schwab Controlling Balm with Tea Tree Oil, Salicyclic Acid 0.8%, 1 FL OZ/ 30 ML per tube, Doctor D. Schwab, A division of CA BOTANA, San Diego, CA 92123. NDC: 35192-016-05”
Why was Doctor D. Schwab Controlling Balm with Tea Tree Oil recalled?
According to the FDA, the stated reason for the recall is: “CGMP Deviations.” In plain terms, this recall relates to a manufacturing quality issue (CGMP).
CGMP stands for Current Good Manufacturing Practice — the FDA's quality rules for how medicines must be made, tested, and documented. A CGMP-related recall means the manufacturing process did not meet those standards. It does not automatically mean the medicine is harmful, but the FDA cannot be confident in its quality, so it is removed from the market.
What should you do?
If you think you may have bought Doctor D. Schwab Controlling Balm with Tea Tree Oil, compare it against the product description and identifying codes (Lot Code D54361, exp 8/31/2027) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact CA BOTANA International, Inc. or your local health authority.
About this recall
This recall was distributed in CA. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- December 3, 2025
- Recall started
- October 10, 2025
- Distributed in
- CA
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Doctor D. Schwab Controlling Balm with Tea Tree Oil recalled?+
According to the FDA: CGMP Deviations
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Doctor D. Schwab Controlling Balm with Tea Tree Oil?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0185-2026. Information last synced from the FDA on July 6, 2026.